Online Only Articles

Concomitant gain of 1q21 and MYC translocation define a poor prognostic subgroup of hyperdiploid multiple myeloma

Department of Internal Medicine V, University of Heidelberg, Germany;Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA
Institute of Human Genetics, University of Heidelberg, Germany
Department of Internal Medicine V, University of Heidelberg, Germany
Division of Biostatistics, German Cancer Research Center, Heidelberg, Germany
Institute of Human Genetics, University of Heidelberg, Germany
Department of Internal Medicine V, University of Heidelberg, Germany
Department of Internal Medicine V, University of Heidelberg, Germany
Department of Hematology and Oncology, Asklepios Klinik Altona, Hamburg, Germany
Department of Medicine III, Charité Campus Benjamin Franklin, Berlin, Germany
Department of Hematology, Oncology and Immunology, University of Tübingen, Germany
Department of Internal Medicine V, University of Heidelberg, Germany
Department of Internal Medicine V, University of Heidelberg, Germany
Department of Internal Medicine V, University of Heidelberg, Germany;National Center for Tumor Diseases, Heidelberg, Germany
Department of Internal Medicine V, University of Heidelberg, Germany;National Center for Tumor Diseases, Heidelberg, Germany
Institute of Human Genetics, University of Heidelberg, Germany
Vol. 101 No. 3 (2016): March, 2016 https://doi.org/10.3324/haematol.2015.136929